Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2659 |
|
Actual shortage: | 251 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2399 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
27 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2020-04-16 | 2020-04-23 | 112367 |
TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2020-05-01 | 2020-05-08 | 113729 |
TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2020-05-01 | 2020-05-21 | 113738 |
TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118922 |
TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2020-08-13 | 2020-10-08 | 122204 |
TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2020-10-01 | 2020-10-22 | 125461 |
TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2021-02-05 | 2021-03-11 | 133448 |
TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2021-04-15 | 2021-05-20 | 137541 |
TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2021-06-17 | 2021-07-09 | 141110 |
TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2021-09-02 | 2021-12-01 | 145115 |
TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2021-09-23 | 2021-11-18 | 146112 |
TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2021-09-30 | 2021-11-11 | 146449 |
TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2021-09-30 | 2021-11-11 | 146456 |
TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2021-10-07 | 2021-11-11 | 146847 |
TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2021-10-14 | 2021-12-17 | 147216 |
TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2021-10-21 | 2021-12-08 | 147705 |
TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2021-12-17 | 2022-01-20 | 151419 |
TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-02-24 | 2022-04-01 | 155557 |
TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2022-03-24 | 2022-03-26 | 157274 |
TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-06-03 | 2022-08-19 | 161949 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-12 | 2018-10-12 | 63943 |
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
TEVA-LENOLTEC NO. 1 | 300MG 8MG 15MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81362 |
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 |